Association between αvβ6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer

Journal of Cellular Biochemistry

Volumn 84, Issue 4, 2002, Pages 675-686

  Ahmed, Nuzhat ^a   Pansino, Franca ^b   Baker, Mark ^a   Rice, Greg ^a   Quinn, Michael ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

v 6 integrin; Epithelial cells; Metastasis; Ovarian cancer

Indexed keywords

COLLAGEN TYPE 4; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALPHAVBETA6 INTEGRIN; CELL SURFACE RECEPTOR; ENZYME INHIBITOR; ENZYME PRECURSOR; GELATINASE A; GELATINASE B; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRILE; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS; TUMOR ANTIGEN; UROKINASE;

ARTICLE; CANCER GROWTH; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; BIOSYNTHESIS; CELL CULTURE; CULTURE MEDIUM; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; METABOLISM; OVARY TUMOR; PATHOLOGY; SECRETION;

ANTIGENS, NEOPLASM; BUTADIENES; COLLAGEN TYPE IV; CULTURE MEDIA, CONDITIONED; ENZYME INHIBITORS; ENZYME PRECURSORS; EPITHELIAL CELLS; FEMALE; GENISTEIN; HUMANS; INTEGRINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; OVARIAN NEOPLASMS; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036007394     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10080     Document Type: Article

References (39)

1. The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain
2. The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells
3. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype
4. Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1
5. A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells
6. Polarization of the alpha 6 beta 4 integrin in ovarian carcinomas
7. Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues
8. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling
9. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin
10. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
11. The MAP kinase cascade
12. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer
13. Regulation of tumor cell invasion by extracellular matrix
14. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer
15. Vascular integrin alpha(v)beta3: A new prognostic indicator in breast cancer
16. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes
17. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades
18. Keratinocytes in human wounds express alpha v beta 6 integrin
19. Constitutive activation of the ERK-MAP kinase pathway in human tumors
20. Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: Up-regulation of p27Kip1
21. Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin
22. Integrins: Versatility, modulation, and signaling in cell adhesion
23. Changes in the expression of alpha v integrins in oral squamous cell carcinomas
24. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3
25. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes
26. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade
27. Integrin-mediated activation of MAP kinase is independent of FAK: Evidence for dual integrin signaling pathways in fibroblasts
28. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma
29. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2betal integrin
30. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines
31. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival
32. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion
33. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-beta(1) in transformed keratinocytes
34. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
35. AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9
36. Alphavbeta6 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes
37. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression
38. RGD-containing peptides inhibit experimental peritoneal seeding of human ovarian cancer cells
39. Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium